Join us to talk about the discovery of some of the most amazing medicines that changed the face of treatment for patients with heart failure. Reducing the death sentence that congestive heart failure with a pharmacological drug is no mean feat. Our guest, Robert Ruffolo Jr has accomplished this feat as the lead scientist for Carvedilol, the first beta-blocker ever to be approved for heart failure. He did this in the face of adversity and with a lot of scientific rigor and audacity.
This is a story of how science improves patient’s lives, literally.